Molecular mechanisms of asymmetric RAF dimer activation

Biochemical Society Transactions

Volumn 42, Issue 4, 2014, Pages 784-790

  Jambrina, Pablo G ^a   Bohuszewicz, Olga ^a   Buchete, Nicolae Viorel ^b   Kolch, Walter ^b   Rosta, Edina ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Dimerization; Extracellular signal regulated kinase signalling pathway (ERK signalling pathway); Molecular dynamics (MD); Phosphorylation; RAF

Indexed keywords

DIMER; RAF PROTEIN; CYCLIN DEPENDENT KINASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR;

ASYMMETRIC SYNTHESIS; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DIMERIZATION; ENZYME ACTIVATION; ENZYME CONFORMATION; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; HUMAN; MOLECULAR DYNAMICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIN-DEPENDENT KINASE 2; HUMANS; MAP KINASE SIGNALING SYSTEM; MOLECULAR DYNAMICS SIMULATION; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; RAF KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84905824640     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140025     Document Type: Conference Paper

References (49)

1. Westheimer, F. (1987) Why Nature chose phosphates. Science 235, 1173-1178
2. Kamerlin, S.C.L., Sharma, P.K., Prasad, R.B. and Warshel, A. (2013) Why Nature really chose phosphate. Q. Rev. Biophys. 46, 1-132
3. Hunter, T. (2012) Why Nature chose phosphate to modify proteins. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2513-2516
4. Chang, F., Steelman, L.S., Lee, J.T., Shelton, J.G., Navolanic, P.M., Blalock, W.L., Franklin, R.A. and McCubrey, J.A. (2003) Signal transduction mediated by the Ras//Raf//MEK//ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17, 1263-1293
5. Roberts, P.J. and Der, C.J. (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291-3310
6. Peyssonnaux, C. and Eychéne, A. (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 93, 53-62
7. Mercer, K.E. and Pritchard, C.A. (2003) Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 1653, 25-40
8. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W. et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417, 949-954
9. Bollag, G., Tsai, J., Zhang, J., Zhang, C., Ibrahim, P., Nolop, K. and Hirth, P. (2012) Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat. Rev. Drug Discov. 11, 873-886
10. Mason, C.S., Springer, C.J., Cooper, R.G., Superti-Furga, G., Marshall, C.J. and Marais, R. (1999) Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18, 2137-2148
11. Bayliss, R., Fry, A., Haq, T. and Yeoh, S. (2012) On the molecular mechanisms of mitotic kinase activation. Open Biol. 2, 120136
12. Gerlits, O., Waltman, M.J., Taylor, S., Langan, P. and Kovalevsky, A. (2013) Insights into the phosphoryl transfer catalyzed by cAMP-dependent protein kinase: an X-ray crystallographic study of complexes with various metals and peptide substrate SP20. Biochemistry 52, 3721-3727
13. Pesnot, T., Jorgensen, R., Palcic, M.M. and Wagner, G.K. (2010) Structural and mechanistic basis for a new mode of glycosyltransferase inhibition. Nat. Chem. Biol. 6, 321-323
14. Sahún-Roncero, M., Rubio-Ruiz, B., Saladino, G., Conejo-García, A., Espinosa, A., Velázquez-Campoy, A., Gervasio, F.L., Entrena, A. and Hurtado-Guerrero, R. (2013) The mechanism of allosteric coupling in choline kinase 1 revealed by the action of a rationally designed inhibitor. Angew. Chem. Int. Ed. 52, 4582-4586
15. Zhang, X., Gureasko, J., Shen, K., Cole, P.A. and Kuriyan, J. (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137-1149
16. Zhang, X., Pickin, K.A., Bose, R., Jura, N., Cole, P.A. and Kuriyan, J. (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450, 741-744
17. Qiu, C., Tarrant, M.K., Choi, S.H., Sathyamurthy, A., Bose, R., Banjade, S., Pal, A., Bornmann, W.G., Lemmon, M.A., Cole, P.A. and Leahy, D.J. (2008) Mechanism of activation and inhibition of the HER4/ErbB4 kinase. Structure 16, 460-467
18. Garnett, M.J., Rana, S., Paterson, H., Barford, D. and Marais, R. (2005) Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol. Cell 20, 963-969
19. Heldin, C.-H. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223
20. Jeffrey, P.D., Russo, A.A., Polyak, K., Gibbs, E., Hurwitz, J., Massague, J. and Pavletich, N.P. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313-320
21. Vinson, C., Myakishev, M., Acharya, A., Mir, A.A., Moll, J.R. and Bonovich, M. (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 22, 6321-6335
22. Hai, T. and Curran, T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. U.S.A. 88, 3720-3724
23. Ogura, T. and Wilkinson, A.J. (2001) AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 6, 575-597
24. Snider, J., Thibault, G. and Houry, W. (2008) The AAA +superfamily of functionally diverse proteins. Genome Biol. 9, 216
25. Weber, C.K., Slupsky, J.R., Kalmes, H.A. and Rapp, U.R. (2001) Active Ras induces heterodimerization of cRaf and BRaf. Cancer Res. 61, 3595-3598
26. Hatzivassiliou, G., Song, K., Yen, I., Brandhuber, B.J., Anderson, D.J., Alvarado, R., Ludlam, M.J.C., Stokoe, D., Gloor, S.L., Vigers, G. et al. (2010) RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature 464, 431-435
27. Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A. and Kolch, W. (2011) Raf family kinases: old dogs have learned new tricks. Genes Cancer 2, 232-260
28. Poulikakos, P.I., Persaud, Y., Janakiraman, M., Kong, X., Ng, C., Moriceau, G., Shi, H., Atefi, M., Titz, B., Gabay, M.T. et al. (2011) RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480, 387-390
29. Poulikakos, P.I., Zhang, C., Bollag, G., Shokat, K.M. and Rosen, N. (2010) RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 464, 427-430
30. Rushworth, L.K., Hindley, A.D., O'Neill, E. and Kolch, W. (2006) Regulation and role of Raf-1/B-Raf heterodimerization. Mol. Cell. Biol. 26, 2262-2272
31. Jura, N., Shan, Y., Cao, X., Shaw, D.E. and Kuriyan, J. (2009) Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. Proc. Natl. Acad. Sci. U.S.A. 106, 21608-21613
32. Hu, J., Stites, E.C., Yu, H., Germino, E.A., Meharena, H.S., Stork, P.J.S., Kornev, A.P., Taylor, S.S. and Shaw, A.S. (2013) Allosteric activation of functionally asymmetric RAF kinase dimers. Cell 154, 1036-1046
33. Holderfield, M., Merritt, H., Chan, J., Wallroth, M., Tandeske, L., Zhai, H., Tellew, J., Hardy, S., Hekmat-Nejad, M., Stuart, D.D. et al. (2013) RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. Cancer Cell 23, 594-602
34. Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P.N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G. et al. (2010) Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467, 596-599
35. Tsai, J., Lee, J.T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N.K. et al. (2008) Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc. Natl. Acad. Sci. U.S.A. 105, 3041-3046
36. Levinson, N.M., Kuchment, O., Shen, K., Young, M.A., Koldobskiy, M., Karplus, M., Cole, P.A. and Kuriyan, J. (2006) A Src-like inactive conformation in the Abl tyrosine kinase domain. PLoS Biol. 4, e144
37. Shan, Y., Arkhipov, A., Kim, E.T., Pan, A.C. and Shaw, D.E. (2013) Transitions to catalytically inactive conformations in EGFR kinase. Proc. Natl. Acad. Sci. U.S.A. 110, 7270-7275
38. Saladino, G. and Gervasio, F.L. (2012) New insights in protein kinase conformational dynamics. Curr. Top. Med. Chem. 12, 1889-1895
39. Palmieri, L. and Rastelli, G. (2013) C helix displacement as a general approach for allosteric modulation of protein kinases. Drug Discov. Today 18, 407-414
40. Zang, M., Gong, J., Luo, L., Zhou, J., Xiang, X., Huang, W., Huang, Q., Luo, X., Olbrot, M., Peng, Y., Chen, C. and Luo, Z. (2008) Characterization of Ser338 phosphorylation for Raf-1 activation. J. Biol. Chem. 283, 31429-31437
41. Brennan, D.F., Dar, A.C., Hertz, N.T., Chao, W.C.H., Burlingame, A.L., Shokat, K.M. and Barford, D. (2011) A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK. Nature 472, 366-369
42. Yarden, Y. and Sliwkowski, M.X. (2001) Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137
43. Taylor, S.S., Keshwani, M.M., Steichen, J.M. and Kornev, A.P. (2012) Evolution of the eukaryotic protein kinases as dynamic molecular switches. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 2517-2528
44. Dixit, A. and Verkhivker, G.M. (2011) Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases. PLoS Comput. Biol. 7, e1002179
45. Thiel, W. and Hummer, G. (2013) Nobel 2013 Chemistry: methods for computational chemistry. Nature 504, 96-97
46. Arkhipov, A., Shan, Y., Das, R., Endres, N.F., Eastwood, M.P., Wemmer, D.E., Kuriyan, J. and Shaw, D.E. (2013) Architecture and membrane interactions of the EGF receptor. Cell 152, 557-569
47. Sutto, L. and Gervasio, F.L. (2013) Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase. Proc. Natl. Acad. Sci. U.S.A. 110, 10616-10621
48. Montenegro, M., Garcia-Viloca, M., Lluch, J.M. and Gonzalez-Lafont, A. (2011) A QM/MM study of the phosphoryl transfer to the Kemptide substrate catalyzed by protein kinase A: the effect of the phosphorylation state of the protein on the mechanism. Phys. Chem. Chem. Phys. 13, 530-539
49. Groban, E.S., Narayanan, A. and Jacobson, M.P. (2006) Conformational changes in protein loops and helices induced by post-translational phosphorylation. PLoS Comput. Biol. 2, e32